Background Asthma has a significant impact on people of all ages, particularly children. A
lack of universally accepted case definition and confirmatory tests and a poor understanding …

We are currently riding the second wave of the allergy epidemic, which is ongoing in affluent
societies, but now also affecting developing countries. This increase in the prevalence of …

Asthma, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis are
representative chronic respiratory diseases (CRDs). Although they differ in terms of disease …

Allergic diseases affect millions of people worldwide. An increase in their prevalence has
been associated with alterations in the gut microbiome, ie, the microorganisms and their …

Background Asthma and atopic dermatitis (AD) are chronic allergic conditions, along with
allergic rhinitis and food allergy and cause high morbidity and mortality both in children and …

Introduction Epidemiological studies demonstrated that cleaning work and frequent use of
cleaning products are risk factors for asthma. Laundry detergents have been reported to …

Background Asthma is the most common chronic disease in children globally. The Global
Asthma Network (GAN) Phase I study aimed to determine if the worldwide burden of asthma …

Background To gain a global perspective on short-acting β2-agonist (SABA) prescriptions
and associated asthma-related clinical outcomes in patients with asthma, we assessed …

Background: Asthma is a common respiratory disease in children. We aimed to update
information about the incidence and mortality and disability-adjusted life years (DALYs) of …

Abstract Rademikibart (CBP-201) is a next-generation human monoclonal antibody
targeting IL-4Rα, undergoing evaluation in Phase 2 clinical trials for the treatment of …